Wanted: FDA-experienced president for Boston Life Sciences:
This article was originally published in Clinica
Executive Summary
Regulatory, FDA and clinical development exposure will be among the qualities sought by Boston Life Sciences as it begins the search for a new president and CEO. The Boston, Massachusetts development-stage biotechnology company, whose portfolio includes the radioimaging agent Altropane, will use its board meeting this Thursday to find a replacement "promptly", following Dr Robert Rosenthal's sudden decision on Monday to resign and develop a new business venture.